QNTA potential is there… the company is making the right moves to make it happen … IMO anyways .. { … “expansion will increase the reservation's capacity ten-fold and the Company's goal is to be able to produce one million doses of Escozine per month in the near term. As the Company furthers its clinical trials and nutraceutical sales of Escozine, it anticipates that demand will increase exponentially. As such, it has worked with the Ministry of Environment in the DR to secure the appropriate licensing and approvals for the expansion of the reservation and the building of the lab facility.”}
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.